Sanofi diabetes drug Toujeo wins European green light

February 27, 2015 12:26 PM

6 0

Sanofi diabetes drug Toujeo wins European green light

LONDON (Reuters) - French drugmaker Sanofi's new Toujeo diabetes drug has been recommended for approval in Europe, two days after being cleared to go on sale in the United States, regulators said on Friday.

The positive decision from a committee of experts at the European Medicines Agency had been expected and will pave the way for the long-lasting insulin product to go on sale soon in Sanofi's chosen first European markets of Germany and Britain.

Read more

To category page

Loading...